OZEMPIC AND OTHER GLP-1S ARE BEING LINKED TO FEWER SERIOUS INFECTIONS—INCLUDING TB

Summary from the TLDR newsletter

Recent studies have suggested that GLP-1 drugs can reduce the occurrence or severity of certain infections, particularly among more vulnerable groups like people with type 2 diabetes.